Skip to content

MEDICINES CO /DE

Delisted

CIK 1113481fmd_0ZD4M8AEM1WF10F63SXA27YGAGManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2019, 44 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018
Total revenues404438485559625660295143456
Cost of revenue11812915717721723310461477
Gross profit28630832838140842619183(2)(1)
Realized investment gains (losses)–––––––00(52)
Research and development118851101261381409092138133
Selling, general and administrative19415916017224831528521213252
Operating income(25)64588322(28)(185)(222)(665)(191)
Interest expense–008161637444949
Other non-operating income (expense)(3)(0)21110026
Income before taxes(28)64788625(2)(165)21(704)(286)
Income tax expense48(40)(50)352(2)(30)0(97)(51)
Net income from continuing operations(76)1057886230(135)21(608)(235)
Net income(76)1051285116(32)(353)(119)(708)(123)
MEDICINES CO /DE financial statements · FinancialMD